Novartis announces first CAR-T cell therapy BLA for pediatric and young adult patients with r/r B-cell ALL granted … – Yahoo Finance
Endpoints News |
Novartis announces first CAR–T cell therapy BLA for pediatric and young adult patients with r/r B-cell ALL granted …
Yahoo Finance CAR-T is different from typical small molecule or biologic therapies currently on the market because it is manufactured for each individual patient. During the treatment process, T cells are drawn from a patient’s blood and reprogrammed in the … Novartis gets a speedy review for its CAR–T pioneer as FDA lines up a marketing decisionEndpoints News Does the drama of the CAR–T race actually matter?STAT FDA grants priority review to CTL019 for ALLHealio |
|
Genome Editing Market Analysis By Technology (CRISPR, TALEN, ZFN), By Delivery Method (Ex-vivo, In-vivo), By …
MilTech NEW YORK, March 29, 2017 /PRNewswire/ — The global genome editing market is anticipated to reach USD 8.1 billion by 2025, according to a new report by Grand View Research, Inc. Key drivers attributing to the expansion include early applications of … |
Medscape |
Fred Hutch scientists to cover advances in immunotherapy, proteomics at AACR
EurekAlert (press release) Dr. Stanley Riddell, director of the Immunotherapy Integrated Research Center at Fred Hutch and a pioneer in the development of CAR T-cell therapy, will deliver a talk, “Understanding success and failure of T-cell therapy for B-cell malignancies,” on … City of Hope researchers to highlight basic cancer research and population studies at AACR meetingNews-Medical.net |
|
Lawmaker: Stem cell agency ‘boondoggle’ should end
Capitol Weekly A California legislator has launched an effort to terminate the $3 billion California stem cell agency, which is already set to go out of business in about three years. Republican state Sen. John Moorlach of Costa Mesa said in a video, “It’s time to … |
Mirror.co.uk |
Revolutionary ‘BLOOD BREWERY’ stem cell technique could help ease transfusion shortage by growing new cells
Mirror.co.uk These include sickle cell disease, an extremely painful condition that makes red blood cells curved and rigid, and anemia. Scientists are said to be able to reprogram a patient’s red blood cells into master stem cells and then turn them back into red … Inside the BLOOD BREWERY: Incredible stem cell technique could help boost transfusion suppliesDaily Mail Vitro Biopharma Receives Funding to Expand its Stem Cell TherapiesYahoo Finance Pioneering stem cell gene therapy cures infants with bubble baby diseaseUCLA Newsroom Street Register –Ynetnews –Insider Financial all 46 news articles » |